I don't go in for the name calling @thrasher....not defending col@69. His point like many here has the same theme. That is when do we commercialise all the science?just because some pharma unknown wants additional testing on dep drug plus drug, doesn't mean our $ are spent on that research.
The nasal spray may have many options so what, get it launched. What's the hold up?
$48m in bamk after CR, has to be for commercialisation not lab tests.
Are we a research company or a seller of products?
Revenue and SH returns is long overdue.
I don't go in for the name calling @thrasher....not defending...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1784 | 9.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.0¢ | 120000 | 2 |
View Market Depth
| Last trade - 09.08am 25/06/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable